ARCHIVES

Alternative to Animal Use In Research Outlined By OTA

This article is from The Cancer Letter archive.

Vol. 12 No. 08 | February 21, 1986

Download PDF Visit The Full Archive

Related Articles

The Lancet Corrects Henschke Letters.

July 18, 2008

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

In Brief: Little Relation of Cancer Incidence To Known Carcinogens Except For Cigarettes, Holleb Says

July 14, 1978

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978